HIV-associated cognitive neurological disorders (HAND) prevail in the antiretroviral therapy era. Proteomics analysis of CSF revealed expression of Cu/Zn superoxide dismutase (Cu/Zn SOD) in Hispanic women with cognitive impairment (CI). We tested the hypothesis that there is reduced capacity of antioxidant enzymes in CI by measures of expression and activity of Cu/Zn SOD, catalase, and Se-glutathione peroxidase in HAND. Our results showed that the function of these antioxidants was decreased in the CSF and monocytes of women with CI. These findings have important implications regarding their possible contribution to oxidative stress and in the diagnosis and therapy for HAND.
Introduction
HIV-associated neurocognitive disorders (HAND) have remained prevalent after introduction of combined antiretroviral therapy (highly active antiretroviral therapy, HAART) (Brew, 2004; Kolson, 2002; Antinori et al., 2007; Wojna et al., 2006; Meléndez et al., 2008) . Motor and cognitive deficiencies often manifest as mild conditions and persist as patients live longer (Kolson, 2002; Wojna et al., 2006; Fisher-Smith and Rappaport, 2005) . High levels of immunological markers such as tumor necrosis factor-α (TNF-α), interleukin-1, interleukin-6, metalloproteinases, neopterin (Brew et al., 1990) , quinolinic acid (Heyes et al., 1991) , glycoprotein 41 (gp 41) (Adamson et al., 1999) , and macrophage chemotactic protein-1 (MCP-1) (Conant et al., 1998) , in brain tissue or cerebrospinal fluid (CSF) have been regarded as risk factors for neurological decline in the pre-HAART era (Griffin, 1997) . Of these, MCP-1 and TNF alpha are associated with the time to HIV dementia (Sevigny et al., 2004) , or with genetics (MCP-1) in the post-HAART era (Gonzalez et al., 2002; Letendre et al., 2004; Monteiro de Almeida et al., 2005) . However, routinely measured blood tests such as CD4 counts and viral RNA that have been linked to improvement in psychomotor speed performance (Sacktor et al., 2003) , were not associated with the time to HIV dementia in patients receiving HAART (Sevigny et al., 2004) . Since many of these biomarkers are common to other inflammatory diseases, the search for new and combined molecular biomarkers continues to be an objective of active research (Sacktor et al., 2004; Price et al., 2007) .
The neuropathogenesis of HIV infection stems from disrupted cellular networks between peripheral monocytes, tissue macrophages, endothelium, and glia. Increased numbers of peripheral CD14+/CD16+ monocytes have been associated with HAD (Pulliam et al., 1997) . In an animal model of AIDS, invading monocytes from circulation settle into the perivascular space of the brain (Clay et al., 2007; Kim et al., 2006) . Williams et al. (2001) and Fischer-Smith et al. (2001) demonstrated that perivascular macrophages accumulated in SIV and HIVE, respectively. These cells promote pathogenesis by perpetuating the inflammatory process and virus replication in the central nervous system (CNS) (Nath, 1999; Williams and Hickey, 2002) .
Our research focuses on the mechanism of HIV neuropathogenesis in a cohort of Hispanic women characterized for cognitive impairment (CI) while using combined antiretroviral therapy. Differences in the macrophage proteome of women with CI, as compared to that of women with no such impairment, have been reported (Luo et al., 2003) . Our recent CSF proteomics profiling study from the Hispanic cohort revealed unique proteins associated with CI (Laspiur et al., 2007) . Proteins involved in cell signaling, structural function, and antioxidant activities were identified. The cytosolic isoform of Cu/Zn superoxide dismutase (Cu/Zn SOD) was identified from the CSF of 18 Journal of Neuroimmunology 206 (2009) 106-111 
